PIP
PFE icon

Philadelphia Investment Partners’s Pfizer PFE Stock Holding History

Philadelphia Investment Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$241 Hold
10
– – ﹤0.01% 184
2026
Q1 		$281 Buy
+10
New +$266 ﹤0.01% 185

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Philadelphia Investment Partners's PFE Position: Q2 2026 in Review

Philadelphia Investment Partners held its Pfizer (PFE) position steady in Q2 2026 at 10 shares worth $241. The position accounts for ﹤0.01% of the portfolio, ranked #184.

Philadelphia Investment Partners first reported a position in PFE in Q1 2026 and has held it in 2 quarters since. The position peaked at $281 in Q1 2026. 2,813 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Philadelphia Investment Partners held 10 shares of Pfizer worth $241 as of Q2 2026.
  • Philadelphia Investment Partners left its Pfizer share count unchanged in Q2 2026.
  • Pfizer made up ﹤0.01% of Philadelphia Investment Partners's portfolio in Q2 2026, its #184 holding.
  • Philadelphia Investment Partners first reported a position in Pfizer in Q1 2026 and has held it in 2 quarters since.
  • Philadelphia Investment Partners's Pfizer position peaked at $281 in Q1 2026.
  • 2,813 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Philadelphia Investment Partners's 13F filing for Q2 2026, filed 14 Aug 2026.